The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer

Breast cancer is the most common cancer in women worldwide with increasing incidence. Significant therapeutics advances in the field of breast cancer have resulted in a growing number of treatment options, whereas de novo or acquired resistance is still a persistent clinical challenge. Drug resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Liyun, Tang, Shasha, Yu, Haixin, Zhang, Hongyi, Zhang, Yi, Wan, Yuan, Cai, Fengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393754/
https://www.ncbi.nlm.nih.gov/pubmed/36003773
http://dx.doi.org/10.3389/fonc.2022.964934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393754/
https://www.ncbi.nlm.nih.gov/pubmed/36003773
http://dx.doi.org/10.3389/fonc.2022.964934

Ejemplares similares